CD133 and SSEA-1 separations are based on the use of antibodies against unspecified carbohydrate modified epitopes, adding further complexity by suggesting that posttranslational modifications to cell surface proteins are important for cancer stem cell biology [27]. This evidence concerns the gene PROM1 and cancer.